We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Top Buys

Rank Stock Value
1
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$24.1M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$23.4M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$22.7M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$22.6M
5
IBB icon
iShares Biotechnology ETF
IBB
+$15.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$48M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$16.2M
3
EZU icon
iShare MSCI Eurozone ETF
EZU
+$10.9M
4
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$9.69M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$9.09M

Sector Composition

Rank Sector Weight
1 Financials 6.18%
2 Technology 5.91%
3 Industrials 5.3%
4 Consumer Discretionary 4.44%
5 Healthcare 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOPS icon
4201
TOP Ships
TOPS
$4.86M
– –
0
– –
TROO icon
4202
TROOPS Inc
TROO
$238M
$1K ﹤0.01%
168
-1,266
-88% -$4.75K
TRT
4203
Trio-Tech International
TRT
$116M
$1K ﹤0.01%
624
+156
+33% +$272
UUU icon
4204
Universal Safety Products Inc
UUU
$10.5M
$1K ﹤0.01%
232
-638
-73% -$2.44K
VANI icon
4205
Vivani Medical
VANI
$121M
$1K ﹤0.01%
+14
New +$1.46K
VCSH icon
4206
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$1K ﹤0.01%
18
+12
+200% +$963
VCV icon
4207
Invesco California Value Municipal Income Trust
VCV
$528M
$1K ﹤0.01%
100
-455
-82% -$6.39K
VFL
4208
DELISTED
abrdn National Municipal Income Fund
VFL
$1K ﹤0.01%
100
– –
VKTX icon
4209
Viking Therapeutics
VKTX
$3.88B
$1K ﹤0.01%
728
-249
-25% -$328
WRN
4210
Western Copper and Gold
WRN
$543M
$1K ﹤0.01%
+600
New +$376
XTLB
4211
XTL Biopharmaceuticals
XTLB
$6.86M
$1K ﹤0.01%
30
-10
-25% -$215
XTNT icon
4212
Xtant Medical Holdings
XTNT
$42.8M
$1K ﹤0.01%
39
+8
+26% +$206
YINN icon
4213
Direxion Daily FTSE China Bull 3X ETF
YINN
$654M
$1K ﹤0.01%
+5
New +$1.34K
YRD
4214
Yiren Digital
YRD
$106M
$1K ﹤0.01%
100
-20
-17% -$256
XYLO
4215
DELISTED
Xylo Technologies
XYLO
– –
0
– –
ORKA
4216
Oruka Therapeutics
ORKA
$7.29B
$1K ﹤0.01%
1
-3
-75% -$2.22K
GRCE
4217
Grace Therapeutics
GRCE
$45.4M
$1K ﹤0.01%
8
-5
-38% -$340
PVLA
4218
Palvella Therapeutics
PVLA
$2.23B
$1K ﹤0.01%
6
-6
-50% -$920
CSA
4219
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
$1K ﹤0.01%
16
+3
+23% +$102
EGF
4220
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$1K ﹤0.01%
+99
New +$1.35K
HMNF
4221
DELISTED
HMN Financial Inc
HMNF
$1K ﹤0.01%
58
-687
-92% -$8.72K
SDPI
4222
DELISTED
Superior Drilling Products Inc.
SDPI
$1K ﹤0.01%
600
+560
+1,400% +$978
HOLI
4223
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$1K ﹤0.01%
+33
New +$605
OPGN
4224
DELISTED
OpGen, Inc
OPGN
– –
0
– –
NBSE
4225
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1K ﹤0.01%
1
-3
-75% -$3.77K
167 168
169
170 171

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 2.6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.